Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Clinical trial NCT06997198 · RECRUITING

Trial details

NCT number: NCT06997198
Sponsor: University Hospitals Cleveland Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Tardive Dyskinesia Intellectual Disability Developmental Disabilities

Start date: 2026-06-22
Primary completion: 2027-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.